Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1

Conditions

Triple Negative Breast Neoplasms 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Pancreatic Neoplasms 1Ovarian Neoplasms 1Osteosarcoma 1Neoplasms 1Myelodysplastic Syndromes 1Mesothelioma, Malignant 1Mesothelioma 1Lymphoma, Non-Hodgkin 1Leukemia, Prolymphocytic, B-Cell 1Leukemia, Myelomonocytic, Chronic 1Leukemia, Myeloid, Acute 1Leukemia, Lymphocytic, Chronic, B-Cell 1Leukemia, Biphenotypic, Acute 1Kidney Neoplasms 1Glioma 1Colorectal Neoplasms 1Carcinoma, Renal Cell 1Carcinoma, Non-Small-Cell Lung 1Burkitt Lymphoma 1

Interventions

fludarabine 17Cyclophosphamide 15Specimen Handling 14Biopsy 12fludarabine phosphate 11Melphalan 10Cytarabine 10Busulfan 10Mycophenolic Acid 9Whole-Body Irradiation 8Tacrolimus 8venetoclax 7decitabine and cedazuridine drug combination 7Granulocyte Colony-Stimulating Factor 7Injections 6Cyclosporine 6Stem Cell Transplantation 5Sirolimus 5Filgrastim 5Azacitidine 5X-Rays 4Thiotepa 4Peripheral Blood Stem Cell Transplantation 4Idarubicin 4CPX-351 4ruxolitinib 3Magnetic Resonance Spectroscopy 3Hematopoietic Stem Cell Transplantation 3Decitabine 3treosulfan 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Myelodysplastic Syndromes × Blood Component Removal × 30 days × Clear all
NCT06928662 2026-05-15

Chemotherapy (Decitabine in Combination With FLAG-Ida) and Total-Body Irradiation Followed by Donor Stem Cell Transplant for the Treatment of Adults With Myeloid Malignancies at High Risk of Relapse

Fred Hutchinson Cancer Center

Phase 1/2 Recruiting
36 enrolled
MyeloidOther hematologic neoplasm

Myelodysplastic Syndromes, Leukemia, Biphenotypic, Acute, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡